Clobetasol Propionate Gel Recalled Due to Manufacturing Deviations
Teligent Pharma is recalling all unexpired batches of Clobetasol Propionate Gel 0.05% due to deviations from good manufacturing practices. The firm discontinued its stability study program, prompting the recall of 81,883 tubes distributed nationwide and in Puerto Rico.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall. The source text indicates a cGMP deviation (discontinuation of stability studies) rather than confirmed product contamination, manufacturing defect, or reported patient harm. The recall is precautionary in nature based on manufacturing practice deviations, without evidence of adverse events.
Plain-English summary
Teligent Pharma, Inc. is recalling Clobetasol Propionate Gel 0.05% in three package sizes: 15-gram tubes (NDC 52565-082-15), 30-gram tubes (NDC 52565-082-30), and 60-gram tubes (NDC 52565-082-60). A total of 81,883 tubes are affected.
The recall was initiated because the firm is discontinuing its stability study program, which constitutes a deviation from current good manufacturing practice (cGMP) requirements. All products within their expiration dates are included in the recall.
The affected product has been distributed nationwide in the United States and in Puerto Rico. Specific batch numbers and expiration dates are listed in the agency documentation.
Patients who have been prescribed this medication should contact their healthcare provider or pharmacist for guidance on alternative treatments or verification of whether their specific batch is affected.
The recalled product
- Product
- Clobetasol Propionate Gel, 0.05%, packaged in a) 15 grams tube, NDC 52565-082-15; b) 30 grams tube, NDC 52565-082-30; c) 60 grams tube, NDC 52565-082-60, Rx Only, Teligent Pharma, Inc., Buena, NJ 08310.
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical Corticosteroid
- Affected units
- 81,883
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (16)
- Batch: a) 15063
- Exp. 2/28/2022
- 15928
- Exp. 9/30/2022
- 16432
- Exp. 2/28/2023
- 16769
- Exp. 4/30/2023
- b) 15243
- 16628
- Exp. 3/31/2023
- c) 15064
- 15286
- 15287
- 16173
- Exp. 11/30/2022
Distribution
Part of a larger recall action
This product is one of 37 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Teligent Pharma, Inc.
See all →- ModerateDesonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Cream USP 0.1% Recall — Stability Study Discontinuation
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- HighDiflorasone Diacetate Ointment recalled due to discontinued stability studies
FDA (Drugs) · 2022-03-30
- ModerateClobetasol Propionate Cream USP 0.05% Recall for cGMP Deviations
FDA (Drugs) · 2022-03-30
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14